Theralase Technologies Inc. V.TLT

More good news, maybe

[riverrrow]

In the November 2022 report 29 patients had reached 450 days or rather 360 days after ther initial CR at 90 days.  Those patients would have reached 24 months for this November 2023 report.  How many of those patients can still be tracked down for a 24 month followup?  I believe 8 of those 29 patients were CR at 450 days (360 days post 90 day initial CR evaluation).  At least we have a possible trial pool size of up to 29 patients.

[Eoganacht]

Hi riverrow. Right - 29 patients should have reached 24 months post initial response this month. 28% of them were CR at 450 days and 10% were IR. It would be great to know what their status is now.

[enriquesuave]

Nice analysis Eoganacht! If they want to see 18 months post initial CR, then that would be patients who are 21 months in after initial treatment.  Anyone know how many patients hit 21 months post initial treatment?

[Eoganacht]

Hi enrique - six months ago, as of 30 May 2023, 39 patients had hit 450 days (15 months) 9 days from now, all of those 39 patients should have reached 21 months after their first treatment and 18 months after their initial CR.   33% (13 patients) of these 39 patients were CR at 450 days 5% (2 patients) of these 39 patients were IR at 450 days 38% (15) were responders If there is an

[Rumpl3StiltSkin]

True Guys, 29 patients is plenty of CR Data for FDA to decide, NOW, on BTD and perhaps AA. So.....